From the Wires
Seegene to Participate in High Profile Panel on Companion Diagnostics at BIO-Europe 2012
By: Marketwired .
Nov. 7, 2012 11:23 AM
GAITHERSBURG, MD and SEOUL, KOREA -- (Marketwire) -- 11/07/12 -- Seegene Inc., (KOSDAQ: 096530) today announced that the company's Executive Vice President, David L. Dolinger, Ph.D., will participate in a high profile panel on companion diagnostics titled "Reinvigorating pharma pipelines through companion diagnostics" at BIO-Europe 2012, on November 12 in Hamburg, Germany.
Dolinger will be joined by fellow panelists Guy Greiveldinger, Director, BD&L and M&A, Novartis; Bruce Jordan, Senior International Product Manager, Roche Diagnostics; David de Graaf, CEO, Selventa; and moderator Toby Zaleski, Principal, Base Pair Group. BIO-Europe 2012 is the pre-eminent partnering meeting in the life science industry, attracting more than 3,000 executives who will engage in over 15,000 one-to-one partnering meetings.
"BIO-Europe 2012 is a great event to mark Seegene's strides into the companion diagnostic market. Seegene's advanced multiplex molecular diagnostic technologies are well suited to the development of new companion diagnostics tests that can effectively guide personalized therapeutic decision-making," said Dolinger. "Our ability to simultaneously detect multiple analytes from limited patient samples, in a single test, creates diagnostics capable of identifying patients who can truly benefit from the new therapeutics. It also enables our pharmaceutical partners to effectively stratify patient populations for more successful clinical trials."
For more information please visit www.seegene.com or call +301-762-9066.
Latest Cloud Developer Stories
Subscribe to the World's Most Powerful Newsletters
Subscribe to Our Rss Feeds & Get Your SYS-CON News Live!
SYS-CON Featured Whitepapers
Most Read This Week